ROOPA INDUSTRIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.22 INR | -4.48% |
|
-0.80% | +14.57% |
| Sales 2022 | 512M 6.16M 482M | Sales 2023 | 762M 9.16M 717M | Capitalization | 322M 3.88M 304M |
|---|---|---|---|---|---|
| Net income 2022 | 10M 120K 9.42M | Net income 2023 | 13M 156K 12.24M | EV / Sales 2022 | 0.59 x |
| Net Debt 2022 | 105M 1.26M 98.72M | Net Debt 2023 | 169M 2.04M 159M | EV / Sales 2023 | 0.65 x |
| P/E ratio 2022 |
19.4
x | P/E ratio 2023 |
23.9
x | Employees | 59 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.27% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.48% | ||
| 1 week | -0.80% | ||
| Current month | -6.24% | ||
| 1 month | -3.00% | ||
| 3 months | +2.19% | ||
| 6 months | +30.10% | ||
| Current year | +14.57% |
1 week
56.01
62.00
1 month
55.1066.00
Current year
46.3673.20
1 year
37.4073.20
3 years
12.9092.75
5 years
6.8292.75
10 years
5.0092.75
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 31/12/97 | |
| Director of Finance/CFO | - | 30/06/20 | |
| Compliance Officer | - | 31/05/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 31/12/97 | |
| Director/Board Member | 67 | 16/03/97 | |
| Director/Board Member | 67 | 02/11/15 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/05/24 | 59.22 | -4.48% | 2 102 |
| 27/05/24 | 62 | +4.29% | 1,612 |
| 24/05/24 | 59.45 | +0.05% | 5,181 |
| 23/05/24 | 59.42 | +5.62% | 5,093 |
| 22/05/24 | 56.26 | -2.12% | 494 |
Delayed Quote Bombay S.E., May 28, 2024 at 11:00 am
More quotes
Roopa Industries Limited is engaged in active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is engaged in the manufacturing of bulk drugs/drug intermediates. The Companyâs products include N,N- dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is a product used by the manufacturers of the Cephalosporin group of Antibiotics and Statins. It is used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to Agriculture. Glucosamine is a sheet anchor product that is a nutraceutical / nutritional supplement. Bromine And Its Derivatives offers agrochemicals, dyes, various organic and inorganic for medical & veterinary products, gasoline applications, water purification compounds, disinfectants, insecticides, and pesticides.
Sector
Pharmaceuticals
Calendar
28/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +14.57% | 5.87M | |
| +37.52% | 727B | |
| -7.99% | 354B | |
| +15.69% | 328B | |
| -0.53% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| -6.42% | 203B | |
| +3.77% | 164B | |
| -2.15% | 164B |
- Stock Market
- Equities
- ROOPAIND6 Stock
